Search
Browse the Ada Lovelace Institute website.
Filter by:
Active filters:
Invitation to tender: deliberative mini-public on AI and genomic health prediction
Ada and the Nuffield Council on Bioethics are inviting tenders to deliver a deliberative mini-public on AI and genomic health prediction.
The Ada Lovelace Institute in 2022
Ada’s Director Carly Kind reflects on the last year and looks ahead to 2023
Examining the pros and cons of digital COVID certificates in the EU
Can an individualised data technology work in a public health context?
Voices in the Code: A Story about People, Their Values, and the Algorithm They Made
David G. Robinson in conversation with Professor Shannon Vallor
A knotted pipeline
Data-driven systems and inequalities in health and social care
Data-driven responses to the COVID-19 pandemic
What have we learned, and how can we design a future, equitable health and social care system?
From principles to practice: what next for algorithmic impact assessments?
We are convening experts from policy, industry, healthcare and AI ethics to discuss our recent case study and the future of AIAs.
Don’t start with the data: a people-centred approach to addressing health inequalities
Why identities and experiences can’t be reduced to categories
Algorithmic impact assessment: a case study in healthcare
This report sets out the first-known detailed proposal for the use of an algorithmic impact assessment for data access in a healthcare context
Pioneering framework for assessing the impact of medical AI set to be trialled by NHS in world-first pilot
The Ada Lovelace Institute has designed an algorithmic impact assessment (AIA) for the NHS AI Lab, the first known example within healthcare.
Checkpoints for vaccine passports
Requirements that governments and developers will need to deliver in order for any vaccine passport system to deliver societal benefit
Public lacks access to, and has concerns about discriminatory impact of, COVID-19 related technologies
Findings from a survey of public attitudes towards a range of technologies deployed during the COVID-19 pandemic for health outcomes